Kassifou Traore

Kassifou Traore

Auto-generated profile, based on publicly available information

Kassifou Traore


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2024 in Contemporary Mathematics
Verified
Journal Article
Open access
PDF file
APAZOKPOTA Gantonho Paustella
AZOKPOTA Gantonho Paustella
RNRobinah Nalwanga
Robinah Nalwanga
YMYvette MONTCHO
Yvette MONTCHO
KTKassifou Traoré
Kassifou Traoré
Jonas DoumateJonas Doumate
Jonas Doumate
Romain Lucas Glèlè KakaïRomain Lucas Glèlè Kakaï
Romain Lucas Glèlè Kakaï
(1) Background: The ongoing COVID-19 pandemic has posed significant global challenges; its impact in Africa, in particular, has been a subject of increasing concern. Vaccination against COVID-19 started in many African countries in 2020. Despite the remarkable progress made by a selected number of countries initiating vaccination campaigns in 2020, the global vaccination coverage against the targeted disease remains inadequate. This study aimed to assess the dynamics of COVID-19 in the face of vaccination in Africa. (2) Methods: We used an extended deterministic Susceptible-Exposed-Infectious-Recovered (SEIR)-type model stratified by vaccination status to mathematically analyze the effect of vaccination on the dynamics of COVID-19 in ten African countries, namely: Benin, Namibia, South Africa, Rwanda, Lybia, DRC, Nigeria, Algeria, Gabon and Kenya. We studied some basic properties of the model and derived the control and basic reproduction numbers Rc and R0, respectively. We further utilized the Castillo-Chavez method to investigate the global stability of the model at the disease-free equilibrium point under the condition Rc < 1. In addition, we developed the expressions of the sensitivity and elasticity of the control reproduction number (Rc) with respect to vaccination coverage, level of adherence to control measures (ψu and ψv), infection probabilities, and relative infectiousness of different compartments of Infected. The model was fitted using cumulative daily COVID-19 case data corresponding to each country's third wave of the pandemic. The unknown parameters are estimated using the non-linear least square method. We used the resulting parameter values to compute the sensitivity and elasticity indices. (3) Results: The study demonstrates the importance of sustaining high vaccination coverage and control measures to mitigate COVID-19 transmission in Africa. Results identify vaccination rates and population compliance to control measures as most influential based on sensitivity analysis. (4) Conclusions: By generating evidence tailored to the African context, this research provides crucial insights to inform resource allocation and interventions to combat COVID-19, where needs are greatest.

17 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Romain Lucas Glèlè KakaïRomain Lucas Glèlè Kakaï
Romain Lucas Glèlè Kakaï
YMYvette MONTCHO
Yvette MONTCHO
HTHemaho Beaugard Taboe
Hemaho Beaugard Taboe
KTKassifou Traore
Kassifou Traore
Mpox is an infectious viral disease endemic to Central African countries. It has seen a resurgence in this region, particularly in the Democratic Republic of Congo (DRC), disproportionately affecting children under 15 years. In this study, we developed an age-structured mathematical model to assess the effect of vaccination on Mpox dynamics in the DRC, focusing on children under 15 as the primary target of upcoming vaccination campaigns. The model captures transmission dynamics across different vaccination coverage levels (10%, 20%, 30%, and 40%) and incorporates critical factors such as age-based susceptibility, waning immunity and control measures). Results reveal a peak in MPOX-confirmed cases on September 29, 2024, with 410 cases and four deaths. From January to December 2025, 4860 cases and 52 deaths were predicted, and a higher vaccination coverage (40%) combined with improved non-pharmaceutical interventions (Φ1 = 20%) targeting under-15s could significantly reduce Mpox transmission and burden, with up to 1,800 cases and 17 deaths averted. The findings underscore the importance of vaccination campaigns, coupled with improved public health measures, in mitigating Mpox transmission and alleviating its burden on vulnerable populations. This study provides a framework for evaluating vaccination strategies and their effectiveness in controlling emerging infectious diseases.